Efficacy and Safety of HRS-7535 in for Heart Failure With Preserved Ejection Fraction and Obesity

PHASE2RecruitingINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Adults' Obesity With Heart Failure With Preserved Ejection Fraction

Interventions

DRUG

HRS-7535 tablet

HRS-7535 tablet.

DRUG

HRS-7535 tablet placebo

HRS-7535 tablet placebo.

Trial Locations (1)

RECRUITING

Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY